A retrospective, observational case series of lower-extremity wound management using CompleteFT

Authors

  • Seana Rutherford Healix Wound Care, Cleveland, OH Author
  • Shauna Hill Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences Author
  • Joanna Marquez Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences Author
  • Anna G. McDonald Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences Author
  • Arshdeep Kaur Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences Author

DOI:

https://doi.org/10.63676/fr1wc427

Keywords:

allografts, cellular, acellular and matrix-like products, full thickness allograft, leg ulcer, placental tissue allograft, wound care applications

Abstract

Aims: The aim of this study was to perform a retrospective case series analysis to review the clinical outcomes seen through standard of care (SOC) supplemented with a full-thickness placental tissue allograft in treating four patients with non-healing lower extremity wounds (including venous leg ulcers (VLUs), non-pressure/traumatic wounds, and pressure injuries (PIs)).

Methods: Data were ascertained from a community-based mobile wound center in Cleveland, Ohio, USA (Healix Wound Care). CompleteFT was applied to non-pressure/traumatic injuries (n=3), VLUs (n=3) and PIs (n=1). Changes in wound size, wound bed, and other clinical parameters were recorded and assessed.

Results: Of the seven wounds evaluated (with sizes varying from 2 to 440cm2) for the four patients included in this case series, four wounds healed as early as 2-weeks post CompleteFT application and three wounds saw an attenuation in percent wound surface area as early as 2-weeks post CompleteFT application.

Conclusion: The empirical data from this case series demonstrates the clinical utility of using full-thickness placental tissue allograft on non-healing, chronic lower extremity wounds based on progress toward healing through regular excisional sharp debridement plus the application of a full-thickness placental tissue allograft, supplemented with secondary wound dressing coverage in these four cases.

Author Biographies

  • Seana Rutherford, Healix Wound Care, Cleveland, OH

    DNP, MSN, APRN, FNP-C, CWS, WCC

  • Shauna Hill, Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences

    PhD

  • Joanna Marquez, Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences

    MS

  • Anna G. McDonald, Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences

    MD

  • Arshdeep Kaur, Tiger Medical Holdings, LLC, d/b/a Tiger BioSciences

    MS

References

1. Sen CK. Human Wound and Its Burden: Updated 2022 Compendium of Estimates. Adv Wound Care (New Rochelle). 2023;12(12):657–670. https://doi.org/10.1089/wound.2023.0150

2. Schultz GS, Sibbald RG, Falanga V et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11 Suppl 1:S1–S28. https://doi.org/10.1046/j.1524-475x.11.s2.1.x

3. Protzman NM, Mao Y, Long D et al. Placental-Derived Biomaterials and Their Application to Wound Healing: A Review. Bioengineering (Basel). 2023;10(7):829. https://doi.org/10.3390/bioengineering10070829

4. Elkhenany H, El-Derby A, Abd Elkodous M, Salah RA, Lotfy A, El-Badri N. Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge. Stem Cell Res Ther. 2022;13(1):8. https://doi.org/10.1186/s13287-021-02684-0

5. McQuilling JP, Kammer M, Kimmerling KA, Mowry KC. Characterisation of dehydrated amnion chorion membranes and evaluation of fibroblast and keratinocyte responses in vitro. Int Wound J. 2019;16(3):827–840. https://doi.org/10.1111/iwj.13103

6. Ingraldi AL, Audet RG, Tabor AJ. The preparation and clinical efficacy of amnion-derived membranes: a review. J Funct Biomater. 2023;14(10):531. https://doi.org/10.3390/jfb14100531

7. Dallal MMS, Nikkhahi F, Imeni SM et al. Amniotic membrane transplantation for persistent epithelial defects and ulceration due to Pseudomonas keratitis in a rabbit model. J Ophthalmic Vis Res. 2021;16(4):552–557. https://doi.org/10.18502/jovr.v16i4.9744

8. Roy A, Griffiths S. Intermediate layer contribution in placental membrane allografts. J Tissue Eng Regen Med. 2020;14(8):1126–1135. https://doi.org/10.1002/term.3086

9. Singh P, Easley A, Menchaca KT et al. Comparative study of placental allografts with distinct layer composition. Int J Mol Sci. 2025;26(7):3406. https://doi.org/10.3390/ijms26073406

10. Bull RH, Staines KL, Collarte AJ, Bain DS, Ivins NM, Harding KG. Measuring progress to healing: A challenge and an opportunity. Int Wound J. 2022;19(4):734–740. https://doi.org/10.1111/iwj.13669

11. Lim JJ, Koob TJ. Placental Cells and Tissues: The Transformative Rise in Advanced Wound Care. Worldwide Wound Healing-Innovation in Natural and Conventional Methods. InTech; 2016. https://doi.org/10.5772/65321

Published

2025-04-29

How to Cite

A retrospective, observational case series of lower-extremity wound management using CompleteFT. (2025). International Journal of Tissue Repair, 1(1). https://doi.org/10.63676/fr1wc427